Compounds > atovaquone
Page last updated: 2024-08-25

atovaquone and Leukemia, Myeloid, Acute

atovaquone has been researched along with Leukemia, Myeloid, Acute in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Jacobs, JW; Siddon, AJ1
Devaraj, S; Horvath, TD1
Ball, ZT; Frank, DA; Gaikwad, AS; Hamada, Y; Heppler, LN; Horton, TM; Jiang, K; Krueger, MJ; Long, X; Mangubat-Medina, AE; Munoz, JO; Narayanan, P; Oyadomari, S; Rashid, R; Redell, MS; Seashore, EL; Stevens, AM; Sumazin, P; Terrell, MC; Tošić, I; Walker, SR; Xiang, M1
Anahtar, M; Bar-Natan, M; Blonquist, T; Bradner, JE; Frank, DA; Giaccone, ZT; Heppler, LN; Hetz, C; Ho, VT; Jones, N; Kim, H; Kroll, Y; Liu, S; Marineau, JJ; Neuberg, D; Shaw, D; Soiffer, RJ; Stone, RM; Toniolo, PA; Walker, SR; Xiang, M; Ye, DQ1
Fisher, S; Levy, I; Megged, O; Shalit, I; Stein, J; Yaniv, I1

Other Studies

5 other study(ies) available for atovaquone and Leukemia, Myeloid, Acute

ArticleYear
Concurrent COVID-19 and babesiosis in an older, splenectomized patient.
    Blood, 2021, 11-25, Volume: 138, Issue:21

    Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atovaquone; Azithromycin; Babesiosis; BNT162 Vaccine; COVID-19; COVID-19 Drug Treatment; Fever; Humans; Leukemia, Myeloid, Acute; Male; Parasitemia; Remission Induction; SARS-CoV-2; Splenectomy

2021
Liquid Chromatography-Tandem Mass Spectrometry-Based Therapeutic Monitoring of Plasma Atovaquone Concentrations in Pediatric Patients.
    Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737

    Topics: Antifungal Agents; Atovaquone; Child; Chromatography, Liquid; Humans; Leukemia, Myeloid, Acute; Plant Extracts; Pneumonia, Pneumocystis; Tandem Mass Spectrometry

2024
Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation.
    Blood advances, 2019, 12-23, Volume: 3, Issue:24

    Topics: Activating Transcription Factor 4; Adolescent; Animals; Apoptosis; Atovaquone; Cell Line, Tumor; Cell Survival; Child; Child, Preschool; Disease Models, Animal; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mice; Mice, Knockout; Oxidative Phosphorylation; Signal Transduction; Xenograft Model Antitumor Assays

2019
Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.
    Blood, 2016, 10-06, Volume: 128, Issue:14

    Topics: Animals; Antineoplastic Agents; Apoptosis; Atovaquone; Cell Line, Tumor; Cell Membrane; Cell Survival; Cytokine Receptor gp130; Disease Models, Animal; Down-Regulation; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Mice; Phosphorylation; Phosphotyrosine; STAT3 Transcription Factor; Treatment Outcome

2016
Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation.
    Pediatric transplantation, 2008, Volume: 12, Issue:8

    Topics: Anti-Infective Agents; Atovaquone; Child; Encephalitis; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Time Factors; Toxoplasmosis, Cerebral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2008